The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
Open accessAbstract
Background—: Recent evidence suggests that visit-to-visit variability in systolic blood pressure (SBP) and maximum SBP are predictors of cardiovascular disease. However, it remains uncertain whether these parameters predict the risks of macrovascular and microvascular complications in patients with type 2 diabetes mellitus. Methods and Results—: The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) was a factorial randomized controlled trial of blood pressure lowering and blood glucose control in patients with type 2 diabetes mellitus. The present analysis included 8811 patients without major macrovascular and microvascular events or death during the first 24 months after randomization. SBP variability (defined as standard deviation) and maximum SBP were determined during the first 24 months after randomization. During a median 2.4 years of follow-up from the 24-month visit, 407 major macrovascular (myocardial infarction, stroke, or cardiovascular death) and 476 microvascular (new or worsening nephropathy or retinopathy) events were observed. The association of major macrovascular and microvascular events with SBP variability was continuous even after adjustment for mean SBP and other confounding factors (both P <0.05 for trend). Hazard ratios (95% confidence intervals) for the highest tenth of SBP variability were 1.54 (0.99–2.39) for macrovascular events and 1.84 (1.19–2.84) for microvascular events in comparison with the lowest tenth. For maximum SBP, hazard ratios (95% confidence intervals) for the highest tenth were 3.64 (1.73–7.66) and 2.18 (1.04–4.58), respectively. Conclusion—: Visit-to-visit variability in SBP and maximum SBP were independent risk factors for macrovascular and microvascular complications in type 2 diabetes mellitus. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique Identifier: NCT00145925.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlöf, B., Sever, P. S., & Poulter, N. R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60308-x · Cited by 1,784
Self-citation
Research works printed but not linked: 22
- 10.1136/bmj.321.7258.412 · DOI · Paper page
- 10.1097/HJH.0b013e3281fc975a · DOI · Paper page
- 10.1016/S0140-6736(10)60309-1 · DOI · Paper page
- 10.1016/S0895-7061(97)00277-X · DOI
- 10.1007/s11906-009-0035-4 · DOI · Paper page
- 10.1007/s00125-007-0918-3 · DOI · Paper page
- 10.2337/diacare.26.5.1553 · DOI · Paper page
- 10.1007/s001250100612 · DOI · Paper page
- 10.1016/S0140-6736(07)61303-8 · DOI · Paper page
- 10.1161/01.HYP.24.6.793 · DOI · Paper page
- 10.1097/00004872-200312000-00012 · DOI · Paper page
- 10.1080/10641960601096760 · DOI
- 10.1038/ajh.2009.103 · DOI · Paper page
- 10.1161/hypertensionaha.107.104620 · DOI · Paper page
- 10.1111/j.1365-2362.2011.02574.x · DOI
- 10.1291/hypres.23.553 · DOI
- 10.1038/sj.jhh.1001301 · DOI
- 10.1016/j.atherosclerosis.2011.10.033 · DOI
- 10.2337/dc10-1000 · DOI
- 10.1097/01.hco.0000240587.14463.58 · DOI
- 10.1016/S1474-4422(10)70066-1 · DOI · Paper page
- 10.1016/S0140-6736(10)60235-8 · DOI · Paper page
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationHippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
Stevens, S. L., Wood, S., Koshiaris, C., Law, K., Glasziou, P., Stevens, R. J., & McManus, R. J. (2016) · BMJ · doi:10.1136/bmj.i4098 · Cited by 871
Self-citationMuntner, P., Whittle, J., Lynch, A. I., Colantonio, L. D., Simpson, L. M., Einhorn, P. T., Levitan, E. B., Whelton, P. K., Cushman, W. C., Louis, G. T., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2803 · Cited by 318
Gosmanova, E. O., Mikkelsen, M. K., Molnar, M. Z., Lu, J. L., Yessayan, L. T., Kalantar-Zadeh, K., & Kovesdy, C. P. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.054 · Cited by 293
Metadata
- Authors
- Hata, J., Arima, H., Rothwell, P. M., Woodward, M., Zoungas, S., Anderson, C., Patel, A., Neal, B., Glasziou, P., Hamet, P., Mancia, G., Poulter, N., Williams, B., MacMahon, S., & Chalmers, J.
- Venue
- Circulation
- Published
- 2013-09-17
- Volume
- 128
- Issue
- 12
- Pages
- 1325-1334
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170910845
- Cited by
- 214
- References
- 3
- FWCI
- 11.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial. https://app.cochat.ai/papers/10.1161/circulationaha.113.002717
- The paper
- Hata, J., Arima, H., Rothwell, P. M., Woodward, M., Zoungas, S., Anderson, C., Patel, A., Neal, B., Glasziou, P., Hamet, P., Mancia, G., Poulter, N., Williams, B., MacMahon, S., & Chalmers, J. (2013). Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial. Circulation. https://doi.org/10.1161/circulationaha.113.002717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.